ALC - Alcon reached $199M settlement with J&J Surgical Vision
- Eye care company Alcon ( NYSE: ALC ) has reached a settlement with J&J Surgical Vision on its pending legal proceedings related to femtosecond laser assisted cataract surgery devices.
- The parties have exchanged cross-licenses of certain intellectual property and other mutually agreed covenants and releases, as part of the settlement.
- In addition, Alcon ( ALC ) has agreed to make a one-time payment of $199M to J&J Surgical Vision for those rights and to resolve various worldwide IP disputes relating to this matter.
For further details see:
Alcon reached $199M settlement with J&J Surgical Vision